186 related articles for article (PubMed ID: 29995811)
1. Wilms' tumor 1 (WT1) as a prognosis factor in gynecological cancers: A meta-analysis.
Lu J; Gu Y; Li Q; Zhong H; Wang X; Zheng Z; Hu W; Wen L
Medicine (Baltimore); 2018 Jul; 97(28):e11485. PubMed ID: 29995811
[TBL] [Abstract][Full Text] [Related]
2. Wilms' tumor 1 (WT1) expression and prognosis in solid cancer patients: a systematic review and meta-analysis.
Qi XW; Zhang F; Wu H; Liu JL; Zong BG; Xu C; Jiang J
Sci Rep; 2015 Mar; 5():8924. PubMed ID: 25748047
[TBL] [Abstract][Full Text] [Related]
3. High prognostic value of pre-allogeneic stem cell transplantation minimal residual disease detection by WT1 gene expression in AML transplanted in cytologic complete remission.
Candoni A; De Marchi F; Zannier ME; Lazzarotto D; Filì C; Dubbini MV; Rabassi N; Toffoletti E; Lau BW; Fanin R
Leuk Res; 2017 Dec; 63():22-27. PubMed ID: 29096332
[TBL] [Abstract][Full Text] [Related]
4. Wilms' tumor 1 protein and estrogen receptor beta expression are associated with poor outcomes in uterine carcinosarcoma.
Guntupalli SR; Cao D; Shroff R; Gao F; Menias C; Stewart Massad L; Powell MA; Mutch DG; Thaker PH
Ann Surg Oncol; 2013 Jul; 20(7):2373-9. PubMed ID: 23344579
[TBL] [Abstract][Full Text] [Related]
5. Wilms' tumor 1 antigen immunoreactivity in epithelial ovarian cancer - diagnostic and prognostic value.
Zarychta E; Lepinay K; Szubert S; Jozwicki J; Misiak J; Brozyna AA; Kosinska-Kaczynska K; Lewandowska A; Malicka E; Makarewicz A; Rhone P; Jozwicki W
Folia Histochem Cytobiol; 2020; 58(3):198-207. PubMed ID: 32960974
[TBL] [Abstract][Full Text] [Related]
6. High Ki-67 Immunohistochemical Reactivity Correlates With Poor Prognosis in Bladder Carcinoma: A Comprehensive Meta-Analysis with 13,053 Patients Involved.
Luo Y; Zhang X; Mo M; Tan Z; Huang L; Zhou H; Wang C; Wei F; Qiu X; He R; Chen G
Medicine (Baltimore); 2016 Apr; 95(15):e3337. PubMed ID: 27082587
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of diagnosed WT1 level in acute myeloid leukemia: a meta-analysis.
Yi-Ning Y; Xiao-rui W; Chu-xian Z; Chun W; You-wen Q
Ann Hematol; 2015 Jun; 94(6):929-38. PubMed ID: 25572170
[TBL] [Abstract][Full Text] [Related]
8. Wilms' tumor gene 1 immunotherapy in pelvic gynecological malignancies.
Coosemans A; Vergote I; Van Gool SW
Expert Rev Clin Immunol; 2014 Jun; 10(6):705-11. PubMed ID: 24784346
[TBL] [Abstract][Full Text] [Related]
9. Role of TSP-1 as prognostic marker in various cancers: a systematic review and meta-analysis.
Sun S; Dong H; Yan T; Li J; Liu B; Shao P; Li J; Liang C
BMC Med Genet; 2020 Jun; 21(1):139. PubMed ID: 32600280
[TBL] [Abstract][Full Text] [Related]
10. Transcription factors WT1 and p53 combined: a prognostic biomarker in ovarian cancer.
Carter JH; Deddens JA; Mueller G; Lewis TG; Dooley MK; Robillard MC; Frydl M; Duvall L; Pemberton JO; Douglass LE
Br J Cancer; 2018 Aug; 119(4):462-470. PubMed ID: 30057405
[TBL] [Abstract][Full Text] [Related]
11. Wilms tumor protein 1 (WT1)-- not only a diagnostic but also a prognostic marker in high-grade serous ovarian carcinoma.
Taube ET; Denkert C; Sehouli J; Kunze CA; Dietel M; Braicu I; Letsch A; Darb-Esfahani S
Gynecol Oncol; 2016 Mar; 140(3):494-502. PubMed ID: 26721227
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.
Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G
PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926
[TBL] [Abstract][Full Text] [Related]
13. Wilms tumor gene 1 (WT1) is a prognostic marker in high-grade uterine sarcoma.
Coosemans A; Van Calster B; Verbist G; Moerman P; Vergote I; Van Gool SW; Amant F
Int J Gynecol Cancer; 2011 Feb; 21(2):302-8. PubMed ID: 21734473
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of pretransplantation molecular minimal residual disease assessment by WT1 gene expression in FLT3-positive acute myeloid leukemia.
Candoni A; De Marchi F; Zanini F; Zannier ME; Simeone E; Toffoletti E; Chiarvesio A; Cerno M; Filì C; Patriarca F; Fanin R
Exp Hematol; 2017 May; 49():25-33. PubMed ID: 28159598
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of prognostic value of lncRNA BANCR in tumor patients: A systematic review and meta-analysis.
Zhang G; Cai J
J BUON; 2019; 24(6):2553-2559. PubMed ID: 31983132
[TBL] [Abstract][Full Text] [Related]
16. The prognostic significance of Wilms' tumor gene 1 (WT1) expression at diagnosis in adults with Ph-negative B cell precursor acute lymphoblastic leukemia.
Qin YZ; Jiang Q; Xu LP; Jiang H; Wang Y; Zhao XS; Li ZR; Lai YY; Liu YR; Zhang XH; Liu KY; Huang XJ
Ann Hematol; 2019 Nov; 98(11):2551-2559. PubMed ID: 31493003
[TBL] [Abstract][Full Text] [Related]
17. Measurable residual disease monitoring using Wilms tumor gene 1 expression in childhood acute myeloid leukemia based on child-specific reference values.
Løvvik Juul-Dam K; Guldborg Nyvold C; Vålerhaugen H; Zeller B; Lausen B; Hasle H; Beier Ommen H
Pediatr Blood Cancer; 2019 Jun; 66(6):e27671. PubMed ID: 30900388
[TBL] [Abstract][Full Text] [Related]
18. The Wilms' tumor gene-1 is a prognostic factor in myelodysplastic syndrome: a meta analysis.
Jiang Y; Liu L; Wang J; Cao Z; Zhao Z
Oncotarget; 2018 Mar; 9(22):16205-16212. PubMed ID: 29662637
[TBL] [Abstract][Full Text] [Related]
19. The prognostic nutritional index is prognostic factor of gynecological cancer: A systematic review and meta-analysis.
Wang X; Wang Y
Int J Surg; 2019 Jul; 67():79-86. PubMed ID: 31185310
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Role of High Stathmin 1 Expression in Patients with Solid Tumors: Evidence from a Meta-Analysis.
Mao Q; Chen Z; Wang K; Xu R; Lu H; He X
Cell Physiol Biochem; 2018; 50(1):66-78. PubMed ID: 30278466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]